Drug Chatter -- Tracking biopharma stock chatter

Profile for Five Prime Therapeutics, Inc. (FPRX)

« Back to company index

FPRX Chatter Timeline

Stock Ticker for FPRX

Most Active Tweeters for FPRX

UserTweets
@Pharmdca 12
@srqstockpicker 10
@tgtxdough 10
@portefeuillefun 10
@AmericanBanking 9

Recent Tweets for FPRX

SleekMoneycom @SleekMoneycom
Dimensional Fund Advisors LP Lowers Holdings in Five Prime Therapeutics, Inc. $FPRX https://t.co/W2zbGq1c91
November 19th 2017, 8:11pm
SleekMoneycom @SleekMoneycom
Five Prime Therapeutics, Inc. $FPRX Downgraded by ValuEngine https://t.co/o1Fnb7QE9b
November 19th 2017, 8:11pm
stocknewstimes @stocknewstimes
Five Prime Therapeutics, Inc. $FPRX Downgraded by ValuEngine https://t.co/dznsCl9INw
November 19th 2017, 7:11pm
ledgerzette @ledgerzette
Five Prime Therapeutics, Inc. $FPRX PT Raised to $75.00 https://t.co/ZenjtTjpLk
November 19th 2017, 6:11pm
SPNewsAnalysis @SPNewsAnalysis
Five Prime Therapeutics, Inc. $FPRX Given Average Recommendation of “Hold” by Brokerages https://t.co/JpjaMaSVOs
November 19th 2017, 5:11pm
AmericanBanking @AmericanBanking
Five Prime Therapeutics, Inc. $FPRX Given Average Recommendation of “Hold” by Brokerages https://t.co/1a0RG6zvKY
November 19th 2017, 5:11pm
intercooleronli @intercooleronli
Five Prime Therapeutics, Inc. $FPRX Given Average Recommendation of “Hold” by Brokerages https://t.co/2Sx4dHA2YC
November 19th 2017, 5:11pm
storminvestor @storminvestor
Five Prime Therapeutics, Inc. $FPRX Given Average Recommendation of “Hold” by Brokerages https://t.co/Otq3ChHLjW
November 19th 2017, 5:11pm
CFinancialNews @CFinancialNews
Five Prime Therapeutics, Inc. $FPRX Given Average Recommendation of “Hold” by Brokerages https://t.co/cGYfjQzlvq
November 19th 2017, 5:11pm
ConsumerFeed @ConsumerFeed
Five Prime Therapeutics, Inc. $FPRX Given Average Recommendation of “Hold” by Brokerages https://t.co/hX06wPcUv0 #acn
November 19th 2017, 5:11pm
AmericanBanking @AmericanBanking
Five Prime Therapeutics Gets Average Rating of Hold from Analysts $FPRX https://t.co/9rps04ShfX
November 19th 2017, 5:11pm
finboxio @finboxio
Build-A-Bear Workshop, $FPRX is 34% undervalued and Steven Cohen is a shareholder. Enough said?… https://t.co/FdnKADVksz
November 19th 2017, 8:11am
dispatchtribune @dispatchtribune
FY2017 Earnings Forecast for Five Prime Therapeutics, Inc. Issued By Jefferies Group $FPRX https://t.co/Gyoel44oJI
November 19th 2017, 7:11am
SPNewsAnalysis @SPNewsAnalysis
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Five Prime Therapeutics $FPRX Stock Price https://t.co/PqodVx5MHH
November 18th 2017, 6:11pm
storminvestor @storminvestor
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Five Prime Therapeutics $FPRX Stock Price https://t.co/nAbHW6s1wa
November 18th 2017, 6:11pm
SleekMoneycom @SleekMoneycom
Five Prime Therapeutics, Inc. $FPRX Price Target Increased to $75.00 by Analysts at BMO Capital Markets https://t.co/OPBcvzOMt5
November 18th 2017, 2:11pm
ledgerzette @ledgerzette
Five Prime Therapeutics, Inc. to Post Q4 2017 Earnings of -$1.51 Per Share, Leerink Swann Forecasts $FPRX https://t.co/ugGusyHAhz
November 18th 2017, 11:11am
peterkcrane @peterkcrane
RT @BayAreaBiotechI: Maybe where $FPRX is on the Gartner Hype Cycle #io #csf1r https://t.co/o9JmqBfMnn
November 18th 2017, 8:11am
ledgerzette @ledgerzette
Five Prime Therapeutics, Inc. $FPRX Lowered to Sell at ValuEngine https://t.co/XH8yEA4nFw
November 18th 2017, 8:11am
chillipickle7 @chillipickle7
@BayAreaBiotechI $FPRX $450m end of year EV here. Attractive imo
November 17th 2017, 3:11pm
BayAreaBiotechI @BayAreaBiotechI
Maybe where $FPRX is on the Gartner Hype Cycle #io #csf1r https://t.co/o9JmqBfMnn
November 17th 2017, 1:11pm
ZolmaxNews @ZolmaxNews
Candriam Luxembourg S.C.A. Has $2.05 Million Stake in Five Prime Therapeutics, Inc. $FPRX https://t.co/BaVF0Z0YCC
November 17th 2017, 10:11am
chillipickle7 @chillipickle7
$FPRX maybe severity of post SITC weakness is as much due to lack of major milestones until 2H18 as anything else? https://t.co/sHa4hFc9dT
November 17th 2017, 10:11am
SleekMoneycom @SleekMoneycom
Five Prime Therapeutics, Inc. $FPRX PT Raised to $50.00 https://t.co/EwXOIR1vhM
November 17th 2017, 9:11am
CFinancialNews @CFinancialNews
Five Prime Therapeutics $FPRX versus REGENXBIO $RGNX Head to Head Contrast https://t.co/yUqxJjhVNd
November 16th 2017, 11:11pm
AmericanBanking @AmericanBanking
Five Prime Therapeutics $FPRX versus REGENXBIO $RGNX Head to Head Contrast https://t.co/gVUh5kCFZ9
November 16th 2017, 11:11pm
intercooleronli @intercooleronli
Five Prime Therapeutics $FPRX versus REGENXBIO $RGNX Head to Head Contrast https://t.co/eyya8Rcvnq
November 16th 2017, 11:11pm
Aesculapius1898 @Aesculapius1898
RT @srqstockpicker: $fprx “That’s why this study is provocative: Until this point, there have been no responses with any immunotherapy drug…
November 16th 2017, 6:11pm
dispatchtribune @dispatchtribune
Five Prime Therapeutics, Inc. $FPRX Releases Earnings Results, Misses Expectations By $0.19 EPS https://t.co/i548JlqdM5
November 16th 2017, 2:11pm
srqstockpicker @srqstockpicker
$fprx “That’s why this study is provocative: Until this point, there have been no responses with any immunotherapy… https://t.co/oHmDro7G2m
November 16th 2017, 9:11am
ledgerzette @ledgerzette
Five Prime Therapeutics, Inc. $FPRX Shares Sold by New York State Common Retirement Fund https://t.co/dbsBCpQPXJ
November 16th 2017, 9:11am
srqstockpicker @srqstockpicker
$fprx Why we should be cautiously optimistic about the cabiralizumab plus nivolumab data in pancreatic cancer https://t.co/tqmquoGIjV
November 16th 2017, 9:11am
JustEk33 @JustEk33
Still no rebound in $fprx...not a good look
November 15th 2017, 4:11pm
swonger7 @swonger7
$FPRX Nice bounce over 26 in sea of red. If $IBB r/g this could pop much higher
November 15th 2017, 10:11am
BayAreaBiotechI @BayAreaBiotechI
$ARRY CSF1Ri (SM) seeing some of the same grade 3/4 tox. (elevated CK and AST) as $FPRX CSF1R ab., but less, maybe… https://t.co/y2ztkGMto7
November 14th 2017, 11:11pm
wcumsjy @wcumsjy
RT @AndyBiotech: Timely paper on CSF1R for some new idea on this target after $FPRX $ARRY data at #SITC17 Does CSF1R Blockade Turn into F…
November 14th 2017, 11:11pm
filingBot @filingBot
@WishUponABar I'll keep you updated about new filings for $FPRX Tell your friends, if you like the @filingBot.
November 14th 2017, 9:11pm
WishUponABar @WishUponABar
@filingBot please track $fprx
November 14th 2017, 9:11pm
TheMarketsDaily @TheMarketsDaily
Five Prime Therapeutics, Inc. $FPRX Trading Down 10% https://t.co/LOGXnpyrRf
November 14th 2017, 7:11pm
AndyBiotech @AndyBiotech
Timely paper on CSF1R for some new idea on this target after $FPRX $ARRY data at #SITC17 Does CSF1R Blockade Turn… https://t.co/Yz7IztAPck
November 14th 2017, 7:11pm
filingBot @filingBot
@swonger7 I'll keep you updated about new filings for $FPRX Let others know, if you like the @filingBot
November 14th 2017, 5:11pm
magririzzi @magririzzi
RT @StockMatusow: We think FMR is liquidating several of their #Biotech positions. $FPRX $CALA, and others. Should be over soon, those stoc…
November 14th 2017, 5:11pm
StockMatusow @StockMatusow
We think FMR is liquidating several of their #Biotech positions. $FPRX $CALA, and others. Should be over soon, thos… https://t.co/I9zAGF5hji
November 14th 2017, 5:11pm
srqstockpicker @srqstockpicker
RT @SpeedyCalls: $FPRX 25 Puts SELLING Activity expiring on 16th Mar, Vol 468
November 14th 2017, 4:11pm
swonger7 @swonger7
long $FPRX here 24.93. Bounced to 30 early in the week. Any strength in $IBB and i see this popping back up.
November 14th 2017, 3:11pm
SpeedyCalls @SpeedyCalls
$FPRX 25 Puts SELLING Activity expiring on 16th Mar, Vol 468
November 14th 2017, 1:11pm
dailypoliticaln @dailypoliticaln
Five Prime Therapeutics, Inc. $FPRX Shares Bought by Alps Advisors Inc. https://t.co/opGQYcCN8v
November 14th 2017, 11:11am
dailymailtimes @dailymailtimes
Five Prime Therapeutics, Inc. $FPRX Shares Bought by Alps Advisors Inc. https://t.co/7OwKuxyIrI
November 14th 2017, 11:11am
midetimes @midetimes
Five Prime Therapeutics, Inc. $FPRX Shares Bought by Alps Advisors Inc. https://t.co/Cw18tQAltW
November 14th 2017, 11:11am
WKRBNews @WKRBNews
Five Prime Therapeutics, Inc. $FPRX Shares Bought by Alps Advisors Inc. https://t.co/pbBREYVsie
November 14th 2017, 11:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.